Annual EBIT
-$21.27 M
-$7.27 M-51.90%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual earnings before interest & taxes is -$21.27 million, with the most recent change of -$7.27 million (-51.90%) on December 31, 2023.
- During the last 3 years, DMAC annual EBIT has fallen by -$8.77 million (-70.22%).
- DMAC annual EBIT is now -9637.64% below its all-time high of -$218.40 thousand, reached on December 31, 2005.
Performance
DMAC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$6.88 M
-$1.25 M-22.08%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly earnings before interest & taxes is -$6.88 million, with the most recent change of -$1.25 million (-22.08%) on September 30, 2024.
- Over the past year, DMAC quarterly EBIT has dropped by -$1.73 million (-33.47%).
- DMAC quarterly EBIT is now -111116.13% below its all-time high of $6200.00, reached on March 31, 2005.
Performance
DMAC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$24.11 M
-$1.73 M-7.71%
September 30, 2024
Summary
- As of February 7, 2025, DMAC TTM earnings before interest & taxes is -$24.11 million, with the most recent change of -$1.73 million (-7.71%) on September 30, 2024.
- Over the past year, DMAC TTM EBIT has dropped by -$4.72 million (-24.33%).
- DMAC TTM EBIT is now -248456.70% below its all-time high of -$9700.00, reached on June 1, 2003.
Performance
DMAC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DMAC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.9% | -33.5% | -24.3% |
| 3 y3 years | -70.2% | -101.5% | -64.4% |
| 5 y5 years | -283.4% | -101.5% | -64.4% |
DMAC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.9% | at low | -120.0% | at low | -81.6% | at low |
| 5 y | 5-year | -98.1% | at low | -200.7% | at low | -146.6% | at low |
| alltime | all time | -9637.6% | at low | <-9999.0% | at low | <-9999.0% | at low |
DiaMedica Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.88 M(+22.1%) | -$24.11 M(+7.7%) |
| Jun 2024 | - | -$5.64 M(-1.8%) | -$22.38 M(+4.2%) |
| Mar 2024 | - | -$5.74 M(-1.8%) | -$21.49 M(+1.0%) |
| Dec 2023 | -$21.27 M(+51.9%) | -$5.85 M(+13.4%) | -$21.27 M(+9.7%) |
| Sep 2023 | - | -$5.16 M(+8.8%) | -$19.39 M(+11.7%) |
| Jun 2023 | - | -$4.74 M(-14.1%) | -$17.36 M(+8.6%) |
| Mar 2023 | - | -$5.52 M(+39.0%) | -$15.99 M(+14.2%) |
| Dec 2022 | -$14.00 M(+2.6%) | -$3.97 M(+27.0%) | -$14.00 M(+5.5%) |
| Sep 2022 | - | -$3.13 M(-7.0%) | -$13.27 M(-2.1%) |
| Jun 2022 | - | -$3.36 M(-4.9%) | -$13.56 M(-0.0%) |
| Mar 2022 | - | -$3.54 M(+8.9%) | -$13.56 M(-0.6%) |
| Dec 2021 | -$13.65 M(+9.2%) | -$3.25 M(-5.0%) | -$13.65 M(-7.0%) |
| Sep 2021 | - | -$3.42 M(+1.5%) | -$14.67 M(+0.8%) |
| Jun 2021 | - | -$3.37 M(-7.0%) | -$14.55 M(+5.2%) |
| Mar 2021 | - | -$3.62 M(-15.2%) | -$13.82 M(+10.6%) |
| Dec 2020 | -$12.49 M(+16.4%) | -$4.27 M(+29.6%) | -$12.49 M(+15.7%) |
| Sep 2020 | - | -$3.29 M(+24.6%) | -$10.80 M(+9.0%) |
| Jun 2020 | - | -$2.64 M(+15.5%) | -$9.91 M(+1.3%) |
| Mar 2020 | - | -$2.29 M(-11.2%) | -$9.78 M(-8.9%) |
| Dec 2019 | -$10.74 M(+93.6%) | -$2.58 M(+7.5%) | -$10.74 M(+6.2%) |
| Sep 2019 | - | -$2.40 M(-4.7%) | -$10.11 M(+12.3%) |
| Jun 2019 | - | -$2.52 M(-22.5%) | -$9.00 M(+9.5%) |
| Mar 2019 | - | -$3.25 M(+66.6%) | -$8.22 M(+48.2%) |
| Dec 2018 | -$5.55 M(+29.8%) | -$1.95 M(+51.0%) | -$5.55 M(+16.5%) |
| Sep 2018 | - | -$1.29 M(-25.5%) | -$4.76 M(+13.6%) |
| Jun 2018 | - | -$1.73 M(+201.2%) | -$4.19 M(+19.0%) |
| Mar 2018 | - | -$575.00 K(-50.6%) | -$3.52 M(-16.9%) |
| Dec 2017 | -$4.28 M(+83.8%) | -$1.16 M(+61.5%) | -$4.24 M(+15.5%) |
| Sep 2017 | - | -$720.30 K(-32.2%) | -$3.67 M(-5.1%) |
| Jun 2017 | - | -$1.06 M(-17.7%) | -$3.86 M(+16.9%) |
| Mar 2017 | - | -$1.29 M(+117.3%) | -$3.30 M(+42.0%) |
| Dec 2016 | -$2.33 M(+51.4%) | -$593.70 K(-35.3%) | -$2.33 M(-1.3%) |
| Sep 2016 | - | -$917.40 K(+82.5%) | -$2.36 M(+43.9%) |
| Jun 2016 | - | -$502.70 K(+60.8%) | -$1.64 M(+11.6%) |
| Mar 2016 | - | -$312.60 K(-49.8%) | -$1.47 M(-7.9%) |
| Dec 2015 | -$1.54 M(-67.8%) | -$623.20 K(+214.3%) | -$1.59 M(-7.5%) |
| Sep 2015 | - | -$198.30 K(-40.4%) | -$1.72 M(-28.5%) |
| Jun 2015 | - | -$332.80 K(-24.1%) | -$2.41 M(-27.6%) |
| Mar 2015 | - | -$438.50 K(-41.7%) | -$3.32 M(-32.1%) |
| Dec 2014 | -$4.78 M(-35.5%) | -$752.50 K(-14.9%) | -$4.90 M(-8.1%) |
| Sep 2014 | - | -$884.70 K(-29.2%) | -$5.33 M(-7.4%) |
| Jun 2014 | - | -$1.25 M(-37.9%) | -$5.76 M(-14.0%) |
| Mar 2014 | - | -$2.01 M(+69.7%) | -$6.70 M(-9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$7.41 M(-26.6%) | -$1.19 M(-9.5%) | -$7.40 M(-19.7%) |
| Sep 2013 | - | -$1.31 M(-40.1%) | -$9.22 M(-12.2%) |
| Jun 2013 | - | -$2.19 M(-19.3%) | -$10.50 M(-3.2%) |
| Mar 2013 | - | -$2.71 M(-9.7%) | -$10.85 M(+8.8%) |
| Dec 2012 | -$10.09 M(+51.8%) | -$3.01 M(+16.0%) | -$9.98 M(+12.1%) |
| Sep 2012 | - | -$2.59 M(+2.1%) | -$8.90 M(+10.3%) |
| Jun 2012 | - | -$2.54 M(+38.0%) | -$8.07 M(+14.3%) |
| Mar 2012 | - | -$1.84 M(-4.7%) | -$7.06 M(+3.3%) |
| Dec 2011 | -$6.65 M(+57.5%) | -$1.93 M(+9.4%) | -$6.84 M(+1.1%) |
| Sep 2011 | - | -$1.76 M(+15.6%) | -$6.76 M(+12.3%) |
| Jun 2011 | - | -$1.53 M(-5.6%) | -$6.02 M(+17.4%) |
| Mar 2011 | - | -$1.62 M(-12.9%) | -$5.13 M(+29.6%) |
| Dec 2010 | -$4.22 M(+72.9%) | -$1.86 M(+81.6%) | -$3.96 M(+46.9%) |
| Sep 2010 | - | -$1.02 M(+61.5%) | -$2.69 M(+19.6%) |
| Jun 2010 | - | -$632.50 K(+41.6%) | -$2.25 M(+7.3%) |
| Mar 2010 | - | -$446.70 K(-24.6%) | -$2.10 M(-8.2%) |
| Dec 2009 | -$2.44 M(+44.9%) | -$592.30 K(+2.0%) | -$2.29 M(+23.5%) |
| Sep 2009 | - | -$580.50 K(+21.3%) | -$1.85 M(-6.1%) |
| Jun 2009 | - | -$478.50 K(-24.6%) | -$1.97 M(-8.1%) |
| Mar 2009 | - | -$634.40 K(+301.5%) | -$2.15 M(+10.2%) |
| Dec 2008 | -$1.69 M(-27.0%) | -$158.00 K(-77.5%) | -$1.95 M(-19.4%) |
| Sep 2008 | - | -$701.10 K(+7.4%) | -$2.42 M(+14.1%) |
| Jun 2008 | - | -$652.80 K(+50.1%) | -$2.12 M(-14.5%) |
| Mar 2008 | - | -$435.00 K(-30.7%) | -$2.48 M(+11.9%) |
| Dec 2007 | -$2.31 M(+193.4%) | -$628.00 K(+56.3%) | -$2.21 M(+22.6%) |
| Sep 2007 | - | -$401.80 K(-60.3%) | -$1.81 M(+9.8%) |
| Jun 2007 | - | -$1.01 M(+494.2%) | -$1.65 M(+161.5%) |
| Mar 2007 | - | -$170.50 K(-22.7%) | -$629.20 K(+38.0%) |
| Dec 2006 | -$787.20 K(+260.4%) | -$220.50 K(-8.6%) | -$455.80 K(+58.2%) |
| Sep 2006 | - | -$241.20 K(-8140.0%) | -$288.10 K(+189.5%) |
| Jun 2006 | - | $3000.00(+3.4%) | -$99.50 K(-34.7%) |
| Mar 2006 | - | $2900.00(-105.5%) | -$152.40 K(+2.2%) |
| Dec 2005 | -$218.40 K(-65.7%) | -$52.80 K(+0.4%) | -$149.10 K(-49.8%) |
| Sep 2005 | - | -$52.60 K(+5.4%) | -$297.20 K(+14.4%) |
| Jun 2005 | - | -$49.90 K(-904.8%) | -$259.90 K(-3.7%) |
| Mar 2005 | - | $6200.00(-103.1%) | -$270.00 K(-6.3%) |
| Dec 2004 | -$636.70 K | - | - |
| Dec 2004 | - | -$200.90 K(+1213.1%) | -$288.30 K(+74.3%) |
| Sep 2004 | - | -$15.30 K(-74.5%) | -$165.40 K(-2.2%) |
| Jun 2004 | - | -$60.00 K(+395.9%) | -$169.20 K(+42.3%) |
| Mar 2004 | - | -$12.10 K(-84.5%) | -$118.90 K(+11.3%) |
| Dec 2003 | - | -$78.00 K(+308.4%) | -$106.80 K(+270.8%) |
| Sep 2003 | - | -$19.10 K(+96.9%) | -$28.80 K(+196.9%) |
| Jun 2003 | - | -$9700.00 | -$9700.00 |
FAQ
- What is DiaMedica Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual EBIT year-on-year change?
- What is DiaMedica Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly EBIT year-on-year change?
- What is DiaMedica Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics TTM EBIT year-on-year change?
What is DiaMedica Therapeutics annual earnings before interest & taxes?
The current annual EBIT of DMAC is -$21.27 M
What is the all time high annual EBIT for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual earnings before interest & taxes is -$218.40 K
What is DiaMedica Therapeutics annual EBIT year-on-year change?
Over the past year, DMAC annual earnings before interest & taxes has changed by -$7.27 M (-51.90%)
What is DiaMedica Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of DMAC is -$6.88 M
What is the all time high quarterly EBIT for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly earnings before interest & taxes is $6200.00
What is DiaMedica Therapeutics quarterly EBIT year-on-year change?
Over the past year, DMAC quarterly earnings before interest & taxes has changed by -$1.73 M (-33.47%)
What is DiaMedica Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of DMAC is -$24.11 M
What is the all time high TTM EBIT for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high TTM earnings before interest & taxes is -$9700.00
What is DiaMedica Therapeutics TTM EBIT year-on-year change?
Over the past year, DMAC TTM earnings before interest & taxes has changed by -$4.72 M (-24.33%)